Andrews, M C

Cancer Evolution during Immunotherapy. [electronic resource] - Cell 11 2017 - 740-742 p. digital

Publication Type: Journal Article; Comment

1097-4172

10.1016/j.cell.2017.10.027 doi


Humans
Immunity
Immunotherapy
Melanoma
Nivolumab
Programmed Cell Death 1 Receptor
Tumor Microenvironment